Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Laizhi Luo"'
Autor:
Likun Zhou, Rui Liu, Dingzhi Huang, Hongli Li, Tao Ning, Le Zhang, Shaohua Ge, Ming Bai, Xia Wang, Yuchong Yang, XinYi Wang, Xingyun Chen, Zhiying Gao, Laizhi Luo, Yuanquan Yang, Xi Wu, Ting Deng, Yi Ba
Publikováno v:
EClinicalMedicine, Vol 41, Iss , Pp 101157- (2021)
Background: Chronic oxaliplatin-induced peripheral neurotoxicity (OIPN) is the most troublesome and dose-limiting side effect of oxaliplatin. There is no effective treatment for chronic OIPN. We conducted a randomised controlled trial to investigate
Externí odkaz:
https://doaj.org/article/59dacdc7230a4b8088d7b3cf44d9beeb
Autor:
Jing Bai, Likun Zhou, Wu Sun, Xingyun Chen, Xi Wu, Yonghong Huang, Laizhi Luo, Wei Zhao, Xinyi Wang, Zhiying gao, Huan Wu, Yueting Han, Zhijuan Peng, Yan Sun, Yi Ba, Huimin Yang, Shixia Li
BackgroundNo biomarker was identified for gastric GISTs(GG) detection. We first observed that glands surrounding GG are regionally atrophic. We hypothesize that this local atrophy may mildly reduce pepsinogen Ⅰ(PGⅠ) but the PGⅠ/PGII ratio remai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::035274114aebf110b986493a2975dd02
https://doi.org/10.21203/rs.3.rs-223325/v1
https://doi.org/10.21203/rs.3.rs-223325/v1
Autor:
Libo Li, Likun Zhou, Yanqing Liu, Xi Chen, Huan Wu, Shiyu Hua, Shuping Wang, Laizhi Luo, Zhen Zhou, Zhiying Gao
Publikováno v:
Signal Transduction and Targeted Therapy
Signal Transduction and Targeted Therapy, Vol 5, Iss 1, Pp 1-3 (2020)
Signal Transduction and Targeted Therapy, Vol 5, Iss 1, Pp 1-3 (2020)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce4420d350e81b95dad58c10d491e9a7
http://europepmc.org/articles/PMC7447644
http://europepmc.org/articles/PMC7447644
Autor:
Shaohua Ge, Le Zhang, Laizhi Luo, Rui Liu, Xingyun Chen, Tao Ning, Zhiying gao, Yi Ba, Ming Bai, Dingzhi Huang, Hongli Li, Yuchong Yang, Likun Zhou, Yuanquan Yang, Xinyi Wang, Ting Deng, Xi Wu, Xia Wang
Publikováno v:
EClinicalMedicine
EClinicalMedicine, Vol 41, Iss, Pp 101157-(2021)
EClinicalMedicine, Vol 41, Iss, Pp 101157-(2021)
Background: Chronic oxaliplatin-induced peripheral neurotoxicity (OIPN) is the most troublesome and dose-limiting side effect of oxaliplatin. There is no effective treatment for chronic OIPN. We conducted a randomised controlled trial to investigate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::905cef3ef64454938aad4cf3bde33759
https://doi.org/10.1016/j.eclinm.2021.101157
https://doi.org/10.1016/j.eclinm.2021.101157
Autor:
Kaijun Niu, Laizhi Luo, Xinyi Wang, Yi Ba, Xia Wang, Tao Ning, Le Zhang, Yuchong Yang, Ming Bai, Yuanquan Yang, Hongli Li, Zhiying Gao, Dingzhi Huang, Rui Liu, Rubing Han, Shaohua Ge, Ting Deng, Xi Wu, Xinyun Chen, Zhou Likun
Publikováno v:
Journal of Clinical Oncology. 37:11596-11596
11596 Background: TJMUCH-GI-001 Trial was a randomized, double-blind, placebo-controlled phase III trial to study the efficacy of Monosialotetrahexosylganglioside (GM1) for oxaliplatin-induced peripheral neurotoxicity (OIPN) in GI cancer patients. Ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5e378b0232f0df7e51b99f6d9a42473
https://doi.org/10.1200/jco.2019.37.15_suppl.11596
https://doi.org/10.1200/jco.2019.37.15_suppl.11596
Autor:
Yi Ba, Yuanquan Yang, Shaohua Ge, Le Zhang, Rubing Han, Ming Bai, Dingzhi Huang, Tao Ning, Xinyi Wang, Hongli Li, Laizhi Luo, Rui Liu, Yan Li, Zhiying Gao, Xinyun Chen, Ting Deng, Yuchong Yang, Zhou Likun, Kaijun Niu, Xia Wang
Publikováno v:
Journal of Clinical Oncology. 36:10017-10017
10017Background: Neurotoxicity is the most common dose-limiting toxicity of oxaliplatin. There is no treatment for cumulative sensory neuropathy. This trial is designed to study the efficacy of Mon...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f771094d3ae7672137f2c1fcb4e3a00b
https://doi.org/10.1200/jco.2018.36.15_suppl.10017
https://doi.org/10.1200/jco.2018.36.15_suppl.10017